{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:57:24Z","timestamp":1764997044050},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/md.0000000000001220","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T16:36:07Z","timestamp":1439915767000},"page":"e1220","source":"Crossref","is-referenced-by-count":9,"title":["Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients"],"prefix":"10.1097","volume":"94","author":[{"given":"Nicolas","family":"Leveziel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Ragot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Gand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lichtwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Gozlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Gourdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Fran\u00e7oise","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dured","family":"Dardari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mich\u00e8le","family":"Boissonnot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Piguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Torremocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Jean","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Mar\u00e9chaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210226","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic.","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"key":"R2-6-20210226","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"R3-6-20210226","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11892-012-0283-6","article-title":"Current epidemiology of diabetic retinopathy and diabetic macular edema.","volume":"12","author":"Ding","year":"2012","journal-title":"Curr Diab Rep"},{"key":"R4-6-20210226","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4239\/wjd.v2.i6.98","article-title":"Managing diabetic macular edema: the leading cause of diabetes blindness.","volume":"2","author":"Romero-Aroca","year":"2011","journal-title":"World J Diabetes"},{"key":"R5-6-20210226","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.","volume":"103","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R6-6-20210226","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.ophtha.2006.04.033","article-title":"A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema.","volume":"113","author":"Chun","year":"2006","journal-title":"Ophthalmology"},{"key":"R7-6-20210226","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s001250051594","article-title":"UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.","volume":"44","author":"Stratton","year":"2001","journal-title":"Diabetologica"},{"key":"R8-6-20210226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-6420(95)31052-4","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long term incidence of macular edema.","volume":"102","author":"Klein","year":"1995","journal-title":"Ophthalmology"},{"key":"R9-6-20210226","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ophtha.2008.10.016","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes.","volume":"116","author":"Klein","year":"2009","journal-title":"Ophthalmology"},{"key":"R10-6-20210226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2415-12-11","article-title":"Hospitalized cardiovascular events in patients with diabetic macular edema.","volume":"12","author":"Nguyen-Khoa","year":"2012","journal-title":"BMC Ophthalmol"},{"key":"R11-6-20210226","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2337\/dc11-0079","article-title":"Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies.","volume":"34","author":"Kramer","year":"2011","journal-title":"Diabetes Care"},{"key":"R12-6-20210226","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ophtha.2010.08.040","article-title":"Is diabetic retinopathy related to subclinical cardiovascular disease O","volume":"118","author":"Kawasaki","year":"2011","journal-title":"phthalmology"},{"key":"R13-6-20210226","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/dc12-2264","article-title":"HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study.","volume":"36","author":"Penno","year":"2013","journal-title":"Diabetes Care"},{"key":"R14-6-20210226","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2337\/dc10-2057","article-title":"Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes.","volume":"34","author":"Saulnier","year":"2011","journal-title":"Diabetes Care"},{"key":"R15-6-20210226","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs. An extension of the modified Airlie House Classification. ETDRS report number 10.","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"R16-6-20210226","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.diabres.2009.08.001","article-title":"Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT).","volume":"86","author":"Emanuele","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"R17-6-20210226","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2337\/diacare.19.12.1445","article-title":"Retinopathy predicts coronary heart disease events in NIDDM patients.","volume":"19","author":"Miettinen","year":"1996","journal-title":"Diabetes Care"},{"key":"R18-6-20210226","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2337\/diacare.28.6.1383","article-title":"Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study.","volume":"28","author":"Van Hecke","year":"2005","journal-title":"Diabetes Care"},{"key":"R19-6-20210226","first-page":"398","article-title":"Is diabetic retinopathy an independent risk factor for ischemic stroke S","volume":"38","author":"Cheung","year":"2007","journal-title":"troke"},{"key":"R20-6-20210226","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1464-5491.2007.02327.x","article-title":"Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.","volume":"25","author":"Targher","year":"2008","journal-title":"Diabet Med"},{"key":"R21-6-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/hrt.2008.146670","article-title":"Retinopathy predicts coronary heart disease mortality.","volume":"95","author":"Liew","year":"2009","journal-title":"Heart"},{"key":"R22-6-20210226","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archopht.117.11.1487","article-title":"Association of ocular disease and mortality in a diabetic population.","volume":"117","author":"Klein","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R23-6-20210226","doi-asserted-by":"crossref","first-page":"b4905","DOI":"10.1136\/bmj.b4905","article-title":"Managing complications of the diabetic foot.","volume":"339","author":"Cheer","year":"2009","journal-title":"BMJ"},{"key":"R24-6-20210226","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0140-6736(09)60698-X","article-title":"Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.","volume":"373","author":"Rajamani","year":"2009","journal-title":"Lancet"},{"key":"R25-6-20210226","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.2337\/dc10-1580","article-title":"Targeting the pathophysiology of diabetic macular edema.","volume":"33","author":"Romero-Aroca","year":"2010","journal-title":"Diabetes Care"},{"key":"R26-6-20210226","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/diab.35.4.416","article-title":"Insulin-like growth factor in vitreous. Studies in control and diabetic subjects with neovascularization.","volume":"35","author":"Grant","year":"1986","journal-title":"Diabetes"},{"key":"R27-6-20210226","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI116877","article-title":"Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding protein 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.","volume":"92","author":"Meyer-Schwickerath","year":"1993","journal-title":"J Clin Invest"},{"key":"R28-6-20210226","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.","volume":"118","author":"Adamis","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"R29-6-20210226","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1167\/iovs.10-6644","article-title":"Risk of falls, injurious falls, and other injuries resulting from visual impairment among older adults with age-related macular degeneration.","volume":"52","author":"Wood","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R30-6-20210226","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/tmj.2011.0232","article-title":"Comparison of low-light nonmydriatic digital imaging with 35-mm ETDRS seven-standard field stereo color fundus photographs and clinical examination.","volume":"18","author":"Silva","year":"2012","journal-title":"Telemed J E Health"},{"key":"R31-6-20210226","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ajo.2009.02.031","article-title":"Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields.","volume":"148","author":"Vujosevic","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R32-6-20210226","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ophtha.2004.02.004","article-title":"Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology.","volume":"111","author":"Williams","year":"2004","journal-title":"Ophthalmology"},{"key":"R33-6-20210226","doi-asserted-by":"crossref","first-page":"e14811","DOI":"10.1371\/journal.pone.0014811","article-title":"SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme.","volume":"6","author":"Mackenzie","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:47:21Z","timestamp":1620960441000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201508030-00006"}},"subtitle":["A Multicenter Observational Study"],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":33,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001220","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}